Zydus gets USFDA nod for hypertension drug
New Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Nifedipine extended release tablets used in the treatment of hypertension and chest pain.
The company has received the approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 30mg, 60mg, and 90 mg, Zydus Cadila said in a BSE filing.
The company will produce the drug at the group's formulations manufacturing facility at SEZ, Ahmedabad.
It has more than 180 approvals and so far filed over 310 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd